Morphogenesis (TuHURA Biosciences) focuses on developing innovative therapies that leverage advanced biotechnological approaches to address unmet medical needs. The company is particularly engaged in the field of regenerative medicine, utilizing proprietary technologies to enhance tissue regeneration and repair. Their pipeline includes a range of products aimed at treating various conditions, with an emphasis on harnessing the body's natural healing processes through the application of biomaterials and cellular therapies.

The technologies employed by Morphogenesis are centered around the manipulation of biological systems to promote healing and regeneration. This includes the use of engineered proteins and peptides that can stimulate cellular responses, as well as the development of scaffolds that support tissue growth. By integrating these advanced methodologies, Morphogenesis aims to create effective solutions for conditions that currently lack adequate treatment options, thereby improving patient outcomes and advancing the field of regenerative medicine.

United States

12/14/23- Rebranded as TuHURA Biosciences. Morphogenesis is a clinical stage research and development biotech company with a wide range of enabling cell and gene therapy technologies and a comprehensive product portfolio addressing the detection, monitoring and control of cancer.

Cancer

Immune System Diseases

Lymphatic Diseases

Skin Diseases

Morphogenesis (TuHURA Biosciences)

Skin cancer

IFx-Hu2.0

Biologics

Gene Therapy

Cutaneous squamous cell carcinoma

Metastatic merkel cell carcinoma

B-cell lymphoma

Diffuse large B cell lymphoma

IFx-Hu3.0

Florida

Cell Therapies

Regenerative Medicine

Therapeutic

Morphogenesis (TuHURA Biosciences)

Company Details